Cargando…
Engineering of Live Chimeric Vaccines against Human Metapneumovirus
Human metapneumovirus (HMPV) is an important human pathogen that, along with respiratory syncytial virus (RSV), is a major cause of respiratory tract infections in young infants. Development of an effective vaccine against Pneumoviruses has proven to be particularly difficult; despite over 50 years...
Autores principales: | Ogonczyk Makowska, Daniela, Hamelin, Marie-Ève, Boivin, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168645/ https://www.ncbi.nlm.nih.gov/pubmed/32093057 http://dx.doi.org/10.3390/pathogens9020135 |
Ejemplares similares
-
Avian Cell Line DuckCelt(®)-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac(®)
por: Chupin, Caroline, et al.
Publicado: (2021) -
Effect of In Vitro Syncytium Formation on the Severity of Human Metapneumovirus Disease in a Murine Model
por: Aerts, Laetitia, et al.
Publicado: (2015) -
Persistent Human Metapneumovirus Infection in Immunocompromised Child
por: Abed, Yacine, et al.
Publicado: (2008) -
Modulation of Protease Activated Receptor 1 Influences Human Metapneumovirus Disease Severity in a Mouse Model
por: Aerts, Laetitia, et al.
Publicado: (2013) -
Human metapneumovirus activates NOD-like receptor protein 3 inflammasome via its small hydrophobic protein which plays a detrimental role during infection in mice
por: Lê, Vuong B., et al.
Publicado: (2019)